Phase 1 Study of KH607 Tablets

NCT06393803 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 2mg KH607 tablets
DRUG: 5mg KH607 tablets
DRUG: 10mg KH607 tablets
DRUG: 20mg KH607 tablets
DRUG: 30mg KH607 tablets
DRUG: 40mg KH607 tablets
DRUG: 50mg KH607 tablets
DRUG: 60mg KH607 tablets

Sponsor

Chengdu Kanghong Pharmaceutical Group Co., Ltd.